HCW Biologics Inc (HCWB) Live Share Price, Invest From India

HCW Biologics Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

Day's High
$0.40
Day's Price Range
$0.41
$0.40
2.50%
Upside
52 Week's Low
52 Week's High
$0.25
52-Week Price Range
$17.80
$0.40
37.50%
Downside
4349.98%
Upside

HCW Biologics Inc share price movements today

Previous Close: $0.41
Open: $0.41
Volume: 1.0M
Day's Low - High: $0.40 - $0.41
52 Week Low - High: $0.25 - $17.80

HCW Biologics Inc Historical Returns

1 Month Return: + 42.73 %
3 Month Return: -60.56 %
1 Year Return: -93.86 %
3 Year Return: -99.31 %
5 Year Return: 0 %

HCW Biologics Inc Stock Fundamentals & Key Indicators

Check HCW Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0M

EPS (TTM)

-0.96

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-12.6M

Revenue (TTM)

54.2K

Profit Margin

0.00%

Return On Equity TTM

-27725.96%

HCW Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of HCW Biologics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
HCW Biologics Inc	BUY	$3.0M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.8B	125.53%	74.67	12.55%
Vertex Pharmaceuticals Inc	BUY	$109.3B	101.66%	27.7	32.94%
BeiGene, Ltd.	NA	$33.0B	NA	118.86	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.5B	42.22%	17.12	29.65%

Stock Returns calculator for HCW Biologics Inc Stock including INR - Dollar returns

The HCW Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

HCW Biologics Inc investment value today

Current value as on today

₹6,768

Returns

-₹93,232

(-93.23%)

Returns from HCW Biologics Inc Stock

-₹94,012 (-94.01%)

Dollar Impact

₹780 (+0.78%)

Analyst Recommendation on HCW Biologics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for HCW Biologics Inc. Average target price of $2

HCW Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on HCW Biologics Inc.

What analysts predicted

80%UPSIDE

Target Price

Current Price

$0.4

Analyzed by

8 Analysts

Target

$2.00

HCW Biologics Inc target price $2, a slight upside of 80% compared to current price of $0.4. According to 8 analysts rating.

HCW Biologics Inc Stock’s Investor Sentiment and Interest

Search interest for HCW Biologics Inc Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 6, 2026 to May 6, 2026

Change:-62% versus previous 30 day period

HCW Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	1	1	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-10	-7	-15	-3	-3	-1	-3	-3	-2
EBITDA	-4	-	-7	-14	-3	-1	-1	-1	-4	1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-10	-7	-15	-3	-3	-2	-1	-4	0
Income Tax Expense	0	-	0	0	-	-	-	-	-	-
Net Income	-4	-10	-7	-15	-3	-3	-2	-1	-4	0
Net Profit Margin	-578.90%	-806.69%	-662.82%	-2469.11%	-915.12%	-854.42%	-43373.64%	-29430.99%	-29183.24%	2662.84%

HCW Biologics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	4	4	6	2	2	0
Gross Profit	0	4	0	2	0	0	0
Operating Income	-7	-5	-13	-15	-25	-29	-11
EBITDA	-6	-5	-12	-14	-23	-27	-5
Interest Expense	-	-	0	0	0	1	1
Depreciation	0	0	0	0	1	1	1
Income Before Tax	-7	-5	-12	-14	-24	-30	-7
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-7	-5	-12	-14	-24	-30	-7
Net Profit Margin	0.00%	-140.98%	-313.74%	-221.67%	-879.52%	-1169.70%	-14677.14%

HCW Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-10	-7	-15	-3	-3	-2	-1	-4	0
Operating Cash Flow	-3	-3	-4	-2	-2	-3	-3	-3	-3
Investing Cash Flow	-	0	0	0	0	-	-	-	-
Financing Cash Flow	0	4	1	2	6	0	4	1	4
Change in Cash	-7	0	-2	0	3	-3	1	-1	0

HCW Biologics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-12	-14	-24	-30	-7
Operating Cash Flow	-10	-10	-10	-22	-14	-13
Investing Cash Flow	0	-35	14	3	0	-
Financing Cash Flow	11	49	6	0	15	10
Change in Cash	1	3	10	-18	1	-2

Global Institutional Holdings in HCW Biologics Inc

Funds	Holdings
Advisor Group Holdings, Inc.	0%
Citadel Advisors Llc	0.33%
DRW Securities, LLC	2.54%
UBS Group AG	0%
J.W. COLE ADVISORS, INC.	0.19%

See all

Insights on HCW Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -4.55M → 719.23K (in $), with an average increase of 733.2% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 5.06K → 27.01K (in $), with an average increase of 41.0% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, HCWB stock has moved up by 42.7%
NO EFFECT
Against Peers
In the last 3 years, HCW Biologics Inc has experienced a drawdown of -99.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 92.4%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 27.0% return, outperforming this stock by 120.9%

About HCW Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Organisation	HCW Biologics Inc
Headquarters	2929 North Commerce Parkway, Miramar, FL, United States, 33025
Industry	Biotechnology
CEO	Dr. Hing C. Wong Ph.D.
E-voting on shares	Click here to vote

Key Management of HCW Biologics Inc

Name	Title
Dr. Hing C. Wong Ph.D.	Founder, CEO, Director & Secretary
Dr. Peter Rhode Ph.D.	Chief Scientific Officer & VP of Clinical Operations
Ms. Nicole Valdivieso Esq., J.D.	Vice President of Legal Affairs
Mr. Lee D. Flowers	Senior Vice President of Business Development

FAQs

What is HCW Biologics Inc share price today?

HCW Biologics Inc share price today is $0.4 as on May 6, 2026 at 1:29 am IST at the close of the market. HCW Biologics Inc share today touched a day high of $0.41 and a low of $0.4.

What is the 52 week high and 52 week low for HCW Biologics Inc share?

HCW Biologics Inc share touched a 52 week high of $17.8 on May 13, 2025 and a 52 week low of $0.25 on April 2, 2026. HCW Biologics Inc stock price today i.e. May 6, 2026 at 1:29 am IST is closed at $0.4,which is 97.75% down from its 52 week high and 60.00% up from its 52 week low.

What is HCW Biologics Inc's market capitalisation today?

HCW Biologics Inc market capitalisation is $0.00T as on May 6, 2026 at 1:29 am IST.

How to invest in HCW Biologics Inc Stock (HCWB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for HCW Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in HCW Biologics Inc Shares that will get you 3.7500 shares as per HCW Biologics Inc share price of $0.4 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy HCW Biologics Inc Stock (HCWB) from India?

Indian investors can start investing in HCW Biologics Inc (HCWB) shares with as little as ₹95.28 or $1 (as of May 6, 2026 at 8:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in HCW Biologics Inc stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 8:43 am IST). Based on HCW Biologics Inc share’s latest price of $0.4 as on May 6, 2026 at 1:29 am IST, you will get 25.0000 shares of HCW Biologics Inc. Learn more about fractional shares .